Vasoactive Intestinal Peptide for the treatment of Female Sexual Arousal Disorder
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$225K |
02/15/14 |
10/31/14 |
Vasoactive intestinal peptide for the treatment of psoriasis
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$145K |
09/01/13 |
08/31/14 |
Nanocarrier formulated enzyme for the treatment of S. aureus infection
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$300K |
05/01/13 |
04/30/14 |
Vasoactive intestinal peptide for the treatment of psoriasis
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$227K |
09/07/12 |
08/31/13 |
Nanocarrier formulated enzyme for the treatment of S. aureus infection
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$300K |
05/09/12 |
04/30/13 |
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$432K |
07/01/11 |
03/31/12 |
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$351K |
07/01/10 |
06/30/11 |
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$160K |
04/01/10 |
06/30/10 |
Outpatient treatment for portal hypertension
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$223K |
03/01/10 |
03/28/11 |
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$116K |
03/01/09 |
02/28/11 |
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$959K |
03/01/09 |
02/28/11 |
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$184K |
02/01/09 |
01/31/10 |
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$61.3K |
03/01/08 |
02/28/09 |
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$961K |
03/01/08 |
02/28/09 |
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$200K |
02/15/08 |
01/31/09 |
Long Acting Native GLP-1 formulations for Type 1 Diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
2 |
$915K |
03/15/07 |
02/29/08 |
Targeted formulations of GLP -1 for Type 1 diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$500K |
09/01/05 |
08/31/06 |
Targeted formulations of GLP -1 for Type 1 diabetes
Pharmain Corporation
Principal Investigator
|
HHS |
1 |
$501K |
09/30/04 |
08/31/05 |